Allspring Global Investments
KYMR icon

Allspring Global Investments’s Kymera Therapeutics KYMR Stock Holding History

Allspring Global Investments’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,183
Closed -$72K – 2499
2023
Q3 		$72K Buy
5,183
+1,310
+34% +$26.3K ﹤0.01% 2128
2023
Q2 		$89K Buy
3,873
+53
+1% +$1.52K ﹤0.01% 2099
2023
Q1 		$113K Sell
3,820
-1,075
-22% -$34.7K ﹤0.01% 2008
2022
Q4 		$122K Sell
4,895
-54
-1% -$1.44K ﹤0.01% 1997
2022
Q3 		$107K Sell
4,949
-1,113
-18% -$29.3K ﹤0.01% 2059
2022
Q2 		$119K Sell
6,062
-15,134
-71% -$353K ﹤0.01% 1996
2022
Q1 		$897K Buy
21,196
+865
+4% +$36.5K ﹤0.01% 1950
2021
Q4 		$1.29M Buy
+20,331
New +$1.18M ﹤0.01% 1782

Other funds holding KYMR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return